Use of 3-hydroxyphenylacetylene for activity-dependent, fluorescent labeling of bacteria that degrade toluene via 3-methylcatechol.

J Microbiol Methods

Idaho National Engineering and Environmental Laboratory, PO Box 1625, MS-2203, Idaho Falls, ID 83415, USA.

Published: December 2003

3-hydroxyphenylacetylene (3-HPA) served as a novel, activity-dependent, fluorogenic and chromogenic probe for bacterial enzymes known to degrade toluene via meta ring fission of the intermediate, 3-methylcatechol. By this direct physiological analysis, cells grown with an aromatic substrate to induce the synthesis of toluene-degrading enzymes were fluorescently labeled.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mimet.2003.07.001DOI Listing

Publication Analysis

Top Keywords

degrade toluene
8
3-hydroxyphenylacetylene activity-dependent
4
activity-dependent fluorescent
4
fluorescent labeling
4
labeling bacteria
4
bacteria degrade
4
toluene 3-methylcatechol
4
3-methylcatechol 3-hydroxyphenylacetylene
4
3-hydroxyphenylacetylene 3-hpa
4
3-hpa served
4

Similar Publications

This study investigates the use of nano-sized oxygen bubbles (NOBs) to enhance BTEX (benzene, toluene, ethylbenzene, xylene) biodegradation in groundwater. Optimized NOBs, averaging 155 nm and at a concentration of 6.59 × 10⁸ bubbles/mL, were found to provide sustained oxygen release with a half-life of approximately 50 days.

View Article and Find Full Text PDF

Pifithrin-μ sensitizes mTOR-activated liver cancer to sorafenib treatment.

Cell Death Dis

January 2025

Department of Organ Transplantation and Hepatobiliary Surgery, Key Laboratory of Organ Transplantation of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.

TSC2, a suppressor of mTOR, is inactivated in up to 20% of HBV-associated liver cancer. This subtype of liver cancer is associated with aggressive behavior and early recurrence after hepatectomy. Being the first targeted regimen for advanced liver cancer, sorafenib has limited efficacy in HBV-positive patients.

View Article and Find Full Text PDF

Pretreatment with serine protease inhibitors impairs Leishmania amazonensis survival on macrophages.

Parasit Vectors

January 2025

Laboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz-Fiocruz, Rio de Janeiro, RJ, 21040-360, Brazil.

Background: Leishmaniases are neglected tropical diseases with great clinical and epidemiological importance. The current chemotherapy available for the treatment of leishmaniasis presents several problems, such as adverse effects, toxicity, long treatment time, and parasite resistance. The discovery of new therapeutic alternatives is extremely essential, and the discovery of cellular targets is a tool that helps in the development of new drugs.

View Article and Find Full Text PDF

Toluene Toxicity in the Brain: From Cellular Targets to Molecular Mechanisms.

Annu Rev Pharmacol Toxicol

January 2025

Department of Pharmacology, Addiction Science, and Toxicology, College of Medicine, The University of Tennessee Health Science Center, Memphis, Tennessee, USA; email:

Toluene intoxication constitutes a persistent public health problem worldwide. While most organs can be damaged, the brain is a primary target whether exposure is accidental, occupational, or recreational. Interventions to prevent/revert brain damage by toluene are curtailed by the scarce information on the molecular targets and mechanisms mediating toluene's brain toxicity and the common exposure to other neurotoxins and/or coexistence of neurological/psychiatric disorders.

View Article and Find Full Text PDF

Benzene, toluene, ethylbenzene, and xylene (BTEX) exposure is known to be carcinogenic and neurotoxic chemicals to humans. This study investigates the potential of fungal native strains for the bioremediation of BTEX compounds. Fungal isolates were obtained from BTEX-enriched soil, and their ability to degrade these pollutants was evaluated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!